- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 223/04 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with only hydrogen atoms, halogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 223/04
Total number of patents in this class: 215
10-year publication summary
|
14
|
13
|
16
|
16
|
16
|
16
|
13
|
15
|
14
|
2
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Nocion Therapeutics, Inc. | 45 |
10 |
| 3m Innovative Properties Company | 18406 |
6 |
| Shin-Etsu Chemical Co., Ltd. | 5132 |
5 |
| California Institute of Technology | 3884 |
5 |
| Alkermes Pharma Ireland Limited | 307 |
5 |
| Shire LLC | 48 |
5 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 269 |
4 |
| D.E. Shaw Research, LLC | 77 |
4 |
| Kyushu University, National University Corporation | 1572 |
4 |
| Trevena, Inc. | 66 |
4 |
| Lunella Biotech, Inc. | 93 |
4 |
| F. Hoffmann-La Roche AG | 7958 |
3 |
| BASF SE | 19740 |
3 |
| DSM IP Assets B.V. | 5856 |
3 |
| Northwestern University | 3112 |
3 |
| Capella Therapeutics, Inc. | 16 |
3 |
| Katholieke Universiteit Leuven | 1035 |
3 |
| Marrone Bio Innovations, Inc. | 117 |
3 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
3 |
| Bristol-myers Squibb Company | 5080 |
2 |
| Other owners | 133 |